Researchers at molecular diagnostics company Exact Sciences and Mayo Clinic have identified a blood-based DNA biomarker panel that could help detect hepatocellular carcinoma (HCC), a type of liver cancer.
During the study, the test was used to analyse DNA extracted from the blood samples of 244 subjects, of which 95 people were suffering from different stages of HCC, 51 had cirrhosis and 98 were healthy volunteers.
The samples were assessed for 15 biomarkers in order to detect the combination of six biomarkers yielding the most accurate HCC diagnosis.
